ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

IPG Health Crowned “Healthcare Network of the Year” on Ad Age A-List 2024

NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Today, IPG Health announced that it has been named “Healthcare Network of the Year” on the prestigious Ad Age A-List for the second consecutive year. Recognized for its excellence in areas like EDI and marrying data and AI with creativity, IPG Health is the only healthcare network to receive this distinguishing honor since the category’s introduction last year.

“Part of our ‘secret sauce’ is the broad diversity of our agency brands, approaches and personas across the network, built from the ground up to be interconnected and interoperable, that enables us to create innovative solutions for our clients’ brands and lead the industry,” said Dana Maiman, CEO of IPG Health. “To be recognized on such an esteemed list for the second year in a row is testament to our people’s relentless commitment to doing what’s right for our clients, their brands and for each other every day.”

This recognition builds on another monumental year for the network, marked with trailblazing achievements, including the launch of the first-in-industry clinical trial diversity offering, designed to help clinical trial sponsors diversify their clinical trials and ensure more inclusive treatment innovations. The network also introduced IPG Health Influencer ID (IDI), establishing itself as a leader in the field of social media health influencers and activating influential and authentic voices including patients, caregivers and HCPs to drive clients’ business. In addition, IPG Health invested significantly in further building out its content supply chain offering, integrating applications, harmonizing ways of working, connecting global production centers, and harnessing AI to create a content supply chain purpose-built for healthcare marketing. IPG Health continues to leverage the power of AI, integrating it into all aspects of the business with 100+ use cases in various stages of development/implementation across disciplines.

This coveted recognition comes on the heels of IPG Health agency Neon being recently awarded a “Best Place to Work” by Ad Age and MM+M, and Humancare and YuzuYello which were also named a “Best Place to Work” by MM+M. IPG Health represents the most bespoke and diverse agency solutions with 45+ award-winning agency brands including Full-Service, Medical Communications and Specialty offerings.

For more information, please visit Ad Age's A-List 2024.

About IPG Health
IPG Health is a global collective of the world’s most celebrated and awarded healthcare marketing agencies. We are 6,500+ people across six continents driven by a healthy obsession with creating novel marketing solutions, and harnessing creativity, technology, science, and data to inspire behaviors that fuel better health. With 45+ agencies, including 18+ specialized units, our integrated approach to the full range of communications capabilities ensures we can help clients improve outcomes and quality of life for healthcare audiences around the world. Our clients include the top 20 global pharmaceutical companies as well as countless startups, biotech companies, biopharma companies and a variety of life science companies. IPG Health companies have earned coveted accolades including 2024 Ad Age A-List “Healthcare Network of the Year,” and 2023 “Healthcare Network of the Year” at Cannes Lions, Ad Age A-List, Clio Health Awards, the Manny Awards and the New York Festivals Health Awards, as well as 2023 “Network of the Year” at the London International Awards and MM+M Awards. We are part of the Interpublic Group of Companies (NYSE:IPG). Visit ipghealth.com to learn more.

Contact:
Chido Tsemunhu
718-500-0944
Chido.Tsemunhu@ipghealth.com


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.